Sleep-Deprivation Serum Induces Mitochondrial Stress in BV2 Cells: Responses to P2Y12-Targeted Pharmacological Modulation.
Hao Ya Y, Su Lihan L, Liu Xinghua X, Yao Di D et al.
Sleep deprivation (SD) disrupts neuroimmune and metabolic homeostasis, but whether circulating factors generated after sleep loss alter microglial responses to purinergic pharmacological modulation remains unclear. P2Y12 is a microglia-enriched purinergic receptor that regulates process dynamics, calcium signaling, and microglial interactions with neurons and vascular-glial interfaces. Here, we established an in vitro serum-transfer model to test whether serum from sleep-deprived mice alters mitochondrial and Rhod-2 fluorescence responses to P2Y12-targeted compounds in BV2 cells. Mice were subjected to forced-wheel SD consisting of one wheel revolution every 2 s for 4 h per day over 4 consecutive days, and serum was obtained by cardiac blood collection followed by centrifugation. BV2 cells were treated with control or SD serum in the absence or presence of the P2Y12 antagonist MRS2395 or the P2Y12 agonist 2-MeSADP. Mitochondrial membrane potential was assessed by JC-1 red/green ratio imaging, mitochondrial network integrity by MitoTracker-based segmentation and skeletonization, and Rhod-2 fluorescence responses by single-cell F/F0 imaging. SD serum decreased the JC-1 ratio, increased maximal depolarization, reduced mitochondrial skeleton length and mitochondrial area fraction, and suppressed Rhod-2 responses. Under control-serum conditions, MRS2395 markedly enhanced Rhod-2 responses, whereas the increase in the area under the Rhod-2 response curve with 2-MeSADP was not significant after Holm correction. Under SD-serum conditions, however, neither compound consistently restored the mitochondrial or Rhod-2 response profile. Together, these findings link SD-serum exposure to mitochondrial impairment and attenuated Rhod-2 fluorescence responses in BV2 cells, and suggest that serum context may influence cellular responses to P2Y12-targeted compounds.